April 20, 2026 a 07:43 pm
JNJ: Fundamental Ratio Analysis - Johnson & Johnson
Johnson & Johnson, a key player in the healthcare sector, has strategically refocused its business on innovative medicine and MedTech. This shift aims to leverage higher-growth areas, leaving consumer health to Kenvue Inc. Investors are keenly observing J&J's performance amid these changes.
Fundamental Rating
The fundamental ratings reflect a moderate standing in key financial metrics, with room for improvement.
| Category | Score | Visualization |
|---|---|---|
| Overall | 2 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Historical scores showcase consistency with minor shifts over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-20 | 2 | 4 | 1 | 1 | 1 | 2 | 1 |
| Historical | 0 | 4 | 1 | 1 | 1 | 2 | 1 |
Analyst Price Targets
Analyst targets signal potential growth with a strong consensus on future valuation.
| High | Low | Median | Consensus |
|---|---|---|---|
| $283 | $190 | $250 | $244.33 |
Analyst Sentiment
Analyst sentiment remains positive with a majority leaning towards buy recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 20 | |
| Hold | 17 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Johnson & Johnson's shift towards more growth-centric segments offers potential long-term benefits yet demands strategic execution to mitigate risks stemming from increased competition in pharmaceuticals and MedTech. With a stable historical performance underpinning its innovative ethos, the company's current market evaluation by analysts suggests cautious optimism. The existing fundamental ratings indicate areas for enhancement in financial health and operational efficiencies. While the buy-side sentiment is strong, investors should remain vigilant about possible market shifts affecting the broader healthcare industry. Overall, Johnson & Johnson stands as a resilient entity poised for potential growth in a dynamic landscape.